SCHEMBL30002841

SCHEMBL30002841

O=[N+]([O-])c1ccc(S(=O)(=O)O)cc1.O=[N+]([O-])c1ccc(S(=O)(=O)O)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 7/20 0.61
CA2 P00918 7/20 0.61
CA12 O43570 5/20 0.61
CA9 Q16790 5/20 0.61
CA14 Q9ULX7 5/20 0.61
CA7 P43166 4/20 0.61
CA3 P07451 3/20 0.61
CA4 P22748 3/20 0.61
CA6 P23280 3/20 0.61
CA5A P35218 3/20 0.61
CA13 Q8N1Q1 3/20 0.61
CA5B Q9Y2D0 3/20 0.61
MMP1 P03956 1/20 0.61
MMP2 P08253 1/20 0.61
MMP9 P14780 1/20 0.61
MMP8 P22894 1/20 0.61
MMP13 P45452 1/20 0.61
F2 P00734 2/20 0.55
PRSS1 P07477 2/20 0.55
PRSS2 P07478 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9578 1.00 CA1 (0.61) CA1CA2CA12CA9CA14
SCHEMBL2847705 0.98 CA1 (0.59) CA1CA2CA12CA9CA14
SCHEMBL3851686 0.98 CA1 (0.59) CA1CA2CA12CA9CA14
SCHEMBL27835385 0.98 CA1 (0.59) CA1CA2CA12CA9CA14
Ammonia Solution, Strong SCHEMBL31504474 0.98 CA1 (0.59) CA1CA2CA12CA9CA14
Water SCHEMBL31042482 0.98 CA1 (0.59) CA1CA2CA12CA9CA14
SCHEMBL28692520 0.98 CA1 (0.59) CA1CA2CA12CA9CA14
Iodide SCHEMBL9550510 0.98 CA1 (0.59) CA1CA2CA12CA9CA14
SCHEMBL10441952 0.98 CA1 (0.59) CA1CA2CA12CA9CA14
Fluoride SCHEMBL27433022 0.98 CA1 (0.59) CA1CA2CA12CA9CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4087836-B1 PROCESSES FOR PREPARING TRIAZOLE GLYCOLATE OXIDASE INHIBITORS CANTERO THERAPEUTICS INC (US) 2025-10-08 EP disclosed
WO-2024215907-A1 CRYSTALLINE FORMS OF A 1H-1,2,3-TRIAZOLE-4-CARBOXYLIC ACID COMPOUND Cantero Therapeutics, Inc. (US) 2024-10-17 WO disclosed
WO-2024212137-A1 CRYSTALLINE FORMS OF A 1H-1, 2, 3-TRIAZOLE-4-CARBOXYLIC ACID COMPOUND Cantero Therapeutics, Inc. (US) 2024-10-17 WO disclosed
EP-4087836-A1 PROCESSES FOR PREPARING TRIAZOLE GLYCOLATE OXIDASE INHIBITORS Cantero Therapeutics, Inc. (US) 2022-11-16 EP disclosed